The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells

作者: Julia Starkova , Jozef Madzo , Gunnar Cario , Tomas Kalina , Anthony Ford

DOI: 10.1158/1078-0432.CCR-06-2569

关键词:

摘要: Purpose: Chimeric transcription factor ETV6/RUNX1 (TEL/AML1) is believed to cause pathologic block in lymphoid cell development via interaction with corepressor complex and histone deacetylase. We wanted show the regulatory effect of its reversibility by deacetylase inhibitors (HDACi), as well identify potential ETV6/RUNX1-regulated genes. Experimental Design: used luciferase assay protein, gene, HDACi. To genes, we expression profiling HDACi cells. Next, using flow cytometry quantitative reverse transcription-PCR, measured differentiation changes gene protein after treatment. Results: Luciferase showed repression granzyme B this Proving role ETV6/RUNX1, identified, statistical analysis, 25 genes that are potentially regulated protein. In four selected known cycle regulation ( JunD, ACK1, PDGFRB , TCF4 ), confirmed analysis. After treatment, ETV6/RUNX1-positive cells immunophenotype resembling process compared other leukemic (BCR/ABL, ETV6/PDGFRB positive). Moreover, accumulated G1-G phase whereas B-lineage lines rather unspecific including induction apoptosis decreased proliferation. Conclusions: Presented data support hypothesis affect direct treatment may release aberrant activity caused chimeric factor.

参考文章(50)
T. Tanaka, K. Tanaka, S. Ogawa, M. Kurokawa, K. Mitani, J. Nishida, Y. Shibata, Y. Yazaki, H. Hirai, An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. The EMBO Journal. ,vol. 14, pp. 341- 350 ,(1995) , 10.1002/J.1460-2075.1995.TB07008.X
Daniel G. Tenen, Robert Hromas, Jonathan D. Licht, Dong-Er Zhang, Transcription factors, normal myeloid development, and leukemia. Blood. ,vol. 90, pp. 489- 519 ,(1997) , 10.1182/BLOOD.V90.2.489.489_489_519
Tucker W. LeBien, Fates of Human B-cell Precursors Blood. ,vol. 96, pp. 9- 23 ,(2000) , 10.1182/BLOOD.V96.1.9
Carine Van Lint, Stephane Emiliani, Eric Verdin, The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expression. ,vol. 5, pp. 245- 253 ,(1996)
Florian Otto, Michael Lübbert, Michael Stock, Upstream and downstream targets of RUNX proteins Journal of Cellular Biochemistry. ,vol. 89, pp. 9- 18 ,(2003) , 10.1002/JCB.10491
Dong Hong ZHAO, Jian Jun HONG, Shi Ying GUO, Run Lin YANG, Jun YUAN, Chuan Jun WEN, Kai Ya ZHOU, Chao Jun LI, Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402 Cell Research. ,vol. 14, pp. 74- 80 ,(2004) , 10.1038/SJ.CR.7290205
Scott Hiebert, Bart Lutterbach, Kristie Durst, Lilin Wang, Bryan Linggi, Steve Wu, Lauren Wood, Joseph Amann, Dana King, Yue Hou, Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Cancer Chemotherapy and Pharmacology. ,vol. 48, ,(2001) , 10.1007/S002800100302
Bart Lutterbach, Jennifer J. Westendorf, Bryan Linggi, Stuart Isaac, Edward Seto, Scott W. Hiebert, A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. Journal of Biological Chemistry. ,vol. 275, pp. 651- 656 ,(2000) , 10.1074/JBC.275.1.651
Chongwoo A Kim, Martin L Phillips, Woojae Kim, Mari Gingery, Hoang H Tran, Michael A Robinson, Salem Faham, James U Bowie, Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. The EMBO Journal. ,vol. 20, pp. 4173- 4182 ,(2001) , 10.1093/EMBOJ/20.15.4173